Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Bolsa de Valores de Sao Paulo  >  Fleury S.A.    FLRY3   BRFLRYACNOR5

FLEURY S.A.

(FLRY3)
  Report
End-of-day quote. End-of-day quote Bolsa de Valores de Sao Paulo - 01/22
26.67 BRL   -0.97%
2020FLEURY S.A. : 3rd quarter results
CO
2020FLEURY S.A. : 1st quarter results
CO
2020FLEURY S.A. : 4th quarter results
CO
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bolsa De Valores De Sao P…
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
27.91 27.53 27.22 26.93 26.67 Last
1290500 1333100 1273700 1392200 1334900 Volume
-0.43% -1.36% -1.13% -1.07% -0.97% Change
Financials
Sales 2020 2 809 M 514 M 514 M
Net income 2020 189 M 34,6 M 34,6 M
Net Debt 2020 1 329 M 243 M 243 M
P/E ratio 2020 48,2x
Yield 2020 2,68%
Sales 2021 3 245 M 594 M 594 M
Net income 2021 336 M 61,5 M 61,5 M
Net Debt 2021 1 286 M 235 M 235 M
P/E ratio 2021 24,8x
Yield 2021 2,87%
Capitalization 8 464 M 1 531 M 1 548 M
EV / Sales 2020 3,49x
EV / Sales 2021 3,00x
Nbr of Employees 9 994
Free-Float 57,4%
More Financials
Company
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services. At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands. 
More about the company
Notations Surperformance© of Fleury S.A.
Trading Rating : Investor Rating :
More Ratings
All news about FLEURY S.A.
2020FLEURY S.A. : 3rd quarter results
CO
2020FLEURY S.A. : 1st quarter results
CO
2020FLEURY S.A. : 4th quarter results
CO
2020FLEURY S.A. : Slide show Q4 results
CO
2019FLEURY S.A. : Financial report
CO
2019FLEURY S.A. : 3rd quarter report
CO
2019FLEURY : Half-year results
CO
2019FLEURY : Half-year report
CO
2019FLEURY : Slide show Q1 results
CO
2019NOTICE TO THE MARKET : Re-submission of the Remote Voting Form
PU
2019FLEURY : 1st quarter report
CO
2019FLEURY : Call Notice to Annual Shareholders‘ Meeting
PU
2019FLEURY : Slide show results
CO
2019FLEURY : Annual results
CO
2018FLEURY : 4th quarter report
CO
More news
News in other languages on FLEURY S.A.

- No features available -

More news
Chart FLEURY S.A.
Duration : Period :
Fleury S.A. Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | MarketScreener
Technical analysis trends FLEURY S.A.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 29,44 BRL
Last Close Price 26,67 BRL
Spread / Highest target 42,5%
Spread / Average Target 10,4%
Spread / Lowest Target -6,26%
EPS Revisions
Managers and Directors
NameTitle
Carlos Alberto Iwata Marinelli Chief Executive Officer
Marcio Pinheiro Mendes Chairman
Fernando Augusto Rodrigues Leão Filho Chief Financial & Legal Officer
Edgar Gil Rizzatti Head-Medical, Technical & Process
Samuel Monteiro dos Santos Director
Sector and Competitors
1st jan.Capitalization (M$)
FLEURY S.A.-1.30%1 550
SONIC HEALTHCARE LIMITED10.08%12 942
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.33.86%11 940
NEOGENOMICS, INC.4.07%6 484
DR. LAL PATHLABS LIMITED-1.07%2 594
HEALIUS LIMITED6.17%1 893